Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
Clinical trial NCT03774446 · RECRUITING
Trial details
- NCT number
- NCT03774446
- Sponsor
- Cedars-Sinai Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-02
- Primary completion
- 2026-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.